Abstract:Genome-wide associations studies (GWAS) have identified >400 loci associated with common human diseases. Despite the extraordinary achievement that these results represent, several questions remain unanswered: (i) What is the contribution of rare variants to common diseases not addressed by GWAS? (ii) What are the functional variants underlying the GWAS associations? To answer these questions, we first explored the role of common and rare variants in morbid obesity (BMI>40) by identifying all the variants in the intervals of two endocannabinoid metabolic genes (MGLL and FAAH) using targeted sequencing. We used two different statistical approaches (single marker tests and collapsed markers tests) to identify variants in four intervals associated with high BMI. The majority of the associated variants are located in promoter sequences or in predicted transcriptional enhancers, suggesting their regulatory role. Additionally, we demonstrate that the set of rare variants in the FAAH promoter associated with BMI are also associated with an increased level of anandamide, a FAAH substrate, further suggesting a functional role in obesity. In a second study, we examined one of the most compelling GWAS that had identified SNPs in the 9p21 gene desert associated with coronary artery disease (CAD) and Type 2 diabetes (T2D). We identified 33 enhancers in 9p21; the interval is the second most dense gene-desert for predicted enhancers and is six times denser than the whole genome. The activity of three of these enhancers is affected by regulatory variants that show allelic differences in DNA-protein affinity and are strongly associated with either CAD or T2D. Some of these variants are predicted to disrupt the transcription-binding site relevant to CAD biology. Our study shows that the 9p21 gene desert is significantly enriched in enhancer elements and suggests the associations with CAD and T2D likely result from the cumulative contributions of multiple regulatory variants. Taken together, our studies show that a comprehensive approach of human genetics that integrates rare variants and functional knowledge, such as regulatory elements or metabolic and cell-specific effects, can leverage the findings of GWAS and lead to a deeper functional understanding of the role of genetic variation in human diseases.

Integrative analysis of transcriptome and proteome wide association studies prioritized functional genes for obesity

Proteome and genome integration analysis of obesity

Human brain proteome-wide association study provides insights into the genetic components of protein abundance in obesity

Functional Interrogation Of Enhancer Connectome Prioritizes Candidate Target Genes At Ovarian Cancer Susceptibility Loci

Integrative Analysis of Multi-Omics Data to Detect the Underlying Molecular Mechanisms for Obesity in Vivo in Humans

Identifying BMI-associated genes via a genome-wide multi-omics integrative approach using summary data

Integrating Genetic and Transcriptomic Data to Identify Genes Underlying Obesity Risk Loci

A Genomewide Integrative Analysis of GWAS and Eqtls Data Identifies Multiple Genes and Gene Sets Associated with Obesity

Epigenomic and Transcriptomic Prioritization of Candidate Obesity-Risk Regulatory GWAS SNPs

Genome-wide Association Studies of Common Obesity: Now and Future.

Deciphering the genetic landscape of obesity: a data-driven approach to identifying plausible causal genes and therapeutic targets

Meta-analysis of genome-wide association data identifies novel susceptibility loci for obesity.

Advancement in Genetic Variants Conferring Obesity Susceptibility from Genome-Wide Association Studies

Integrative analysis of omics summary data reveals putative mechanisms underlying complex traits

GWA-based Pleiotropic Analysis Identified Potential SNPs and Genes Related to Type 2 Diabetes and Obesity

Genome Wide Association Study of Obesity.

An integrative framework to prioritize genes in more than 500 loci associated with body mass index

Deciphering the genetic basis of common diseases by integrated functional annotation of common and rare variants

Identification of a 1p21 independent functional variant for abdominal obesity

Biological pathway-based genome-wide association analysis identified the vasoactive intestinal peptide (VIP) pathway important for obesity.

Comprehensive Review And Annotation Of Susceptibility Snps Associated With Obesity-Related Traits